Randomized Trialhigh evidence
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial.
The Lancet. Respiratory medicine·June 9, 2026·PMID 42263720
Why it mattersThis large pragmatic trial provides high-level evidence that sugammadex may modestly reduce postoperative pulmonary complications, primarily atelectasis, in high-risk surgical patients. Anesthesiologists now have comparative effectiveness data to guide reversal agent selection.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled